Finally, four recent clinical studies of heterogeneous series of women with breast tumours examined the possible association between maspin expression (mRNA or protein level) and classical clinical and pathological parameters, including patient outcome (Hojo et al, 2001; Maass et al, 2001a,2001b). This evidence concerns the gene SERPINB5 and breast neoplasm.